Histone Methyltransferases Market

Global Histone Methyltransferases Market: Overview

Histones refer to the main protein constituents that are found in eukaryotic nucleus. This substance, histone methyltransferases, is tasked to play the role of a catalyst in the transfer of methyl group to the arginine and lysine residues of histone protein. The reaction is then catalyzed taking help from SN-2 mechanism in which the methyl group is transferred from S Adenosyl Methionine to the amino group of target lysine. RIZ, SUV4-20, SUV39, SMYD, SET2, SET1, and EZ are the seven histone methyltransferase. Gene regulation is the main task of histone methyltransferase. It also finds use as a biomarker in cancer diagnosis. Increased prevalence of cancer worldwide is expected to trigger growth of the global histone methyltransferases market over the timeframe of analysis, from 2020 to 2030.

Type, application, and region are the three important parameters based on which the global histone methyltransferases market has been classified.

Global Histone Methyltransferases Market: Notable Developments

A recent significant development that is anticipated to influence the future course of the global histone methyltransferases market is mentioned as below

• In May 2020, leading German pharmaceutical company, Boehringer Ingelheim Group acquired Northern Biologics Inc. The latter is a clinical stage company with a portfolio of excellent biologics for solid tumors and its area of focus is therapeutic antibodies that attack the tumor microenvironment. Following the move, Boehringer Ingelheim is anticipated to fortify its position in the field of stromal biology.

Some of the prominent organizations in the global histone methyltransferases market comprise the below-mentioned:

• Diagenode Inc. USA
• Cell Signaling Technology, Inc
• Cayman Chemical Company
• Boehringer Ingelheim GMBH
• Bellbrook Labs
• Constellation Pharmaceuticals

Global Histone Methyltransferases Market: Key Trends

The global histone methyltransferases market is characterized by the presence of the following restraints, drivers, and opportunities.

High Prevalence of Cancer to Drive growth of the Market during the Forecast Period

The growth of the global histone methyltransferases market is estimated to be driven by the surging cases various cancers, such as blood cancer, prostate cancer, lung cancer, and breast cancer. Histone methyltransferases finds increased use in the diagnosis of cancer so as to facilitate treatment.

In addition to that, increased research and development activities for the development of cancer drug along with augmented finding for such activities is estimated to work in favor of the market.

Global Histone Methyltransferases Market: Geographical Analysis

With increased awareness about histone methyltransferase and high prevalence of cancer, North America to remain at the forefront of market growth. In addition, available of favorable reimbursement policies along with huge spending on research and development activities pertaining to cancer treatment is expected to augur well for the regional